Severity: Warning
Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 197
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 197
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 271
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3165
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 597
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 511
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 317
Function: require_once
98%
921
2 minutes
20
Polysaccharide nanoparticles are versatile functional materials used in drug delivery applications. Here we describe a method for the synthesis of β-1,3-glucan esters which show the formation of nanoparticles. Pyridine-soluble β-1,3-glucan formate was first synthesized as an intermediate and then reacted with various anhydrates to yield β-1,3-glucan acetate and hexaonate. The resultant esters were soluble in common organic solvents like acetone, pyridine and dimethylacetamide. By using a simple dialysis process, homogeneous hollow or solid nanospheres with diameter from 132 to 487 nm were prepared. The chemical structures of the obtained β-1,3-glucan esters were characterized and the morphologies of the β-1,3-glucan based nanoparticles were evaluated. These new types of nanoparticles could be potentially used for the encapsulation of hydrophobic drugs targeting immune cells.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.carbpol.2013.06.056 | DOI Listing |